These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2445912)

  • 1. Effects of acute and chronic treatment with imipramine on 5-hydroxytryptamine nerve cell groups and on bulbospinal 5-hydroxytryptamine/substance P/thyrotropin releasing hormone immunoreactive neurons in the rat. A morphometric and microdensitometric analysis.
    Kitayama I; Janson AM; Fuxe K; Agnati LF; Cintra A; Ogren SO; Härfstrand A; Eneroth P; Tsutsumi T; Jonsson G
    J Neural Transm; 1987; 70(3-4):251-85. PubMed ID: 2445912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxytryptamine, substance P, and thyrotropin-releasing hormone in the adult cat spinal cord segment L7: immunohistochemical and chemical studies.
    Arvidsson U; Cullheim S; Ulfhake B; Bennett GW; Fone KC; Cuello AC; Verhofstad AA; Visser TJ; Hökfelt T
    Synapse; 1990; 6(3):237-70. PubMed ID: 1700485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone (TRH)-like immunoreactivity in the grey monkey (Macaca fascicularis) spinal cord and medulla oblongata with special emphasis on the bulbospinal tract.
    Arvidsson U; Ulfhake B; Cullheim S; Shupliakov O; Brodin E; Franck J; Bennett GW; Fone KC; Visser TJ; Hökfelt T
    J Comp Neurol; 1992 Aug; 322(3):293-310. PubMed ID: 1517482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serotoninergic bulbospinal system and brainstem-spinal cord content of serotonin-, TRH-, and substance P-like immunoreactivity in the aged rat with special reference to the spinal cord motor nucleus.
    Johnson H; Ulfhake B; Dagerlind A; Bennett GW; Fone KC; Hökfelt T
    Synapse; 1993 Sep; 15(1):63-89. PubMed ID: 7508641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A thyrotropin-releasing hormone-containing system in the rat dorsal horn separate from serotonin.
    Harkness DH; Brownfield MS
    Brain Res; 1986 Oct; 384(2):323-33. PubMed ID: 3096489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone-immunoreactive neurons project from the ventral medulla to the intermediolateral cell column: partial coexistence with serotonin.
    Helke CJ; Sayson SC; Keeler JR; Charlton CG
    Brain Res; 1986 Aug; 381(1):1-7. PubMed ID: 2428429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of 5-hydroxytryptamine-depleting drugs on peptides in the ventral spinal cord.
    Gilbert RF; Bennett GW; Marsden CA; Emson PC
    Eur J Pharmacol; 1981 Dec; 76(2-3):203-10. PubMed ID: 6174352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin-releasing hormone in spinal cord: coexistence with serotonin and with substance P in fibers and terminals apposing identified preganglionic sympathetic neurons.
    Appel NM; Wessendorf MW; Elde RP
    Brain Res; 1987 Jul; 415(1):137-43. PubMed ID: 2441808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical evidence for the coexistence of substance P, thyrotropin-releasing hormone, GABA, methionine-enkephalin, and leucin-enkephalin in the serotonergic neurons of the caudal raphe nuclei: a dual labeling in the rat.
    Kachidian P; Poulat P; Marlier L; Privat A
    J Neurosci Res; 1991 Nov; 30(3):521-30. PubMed ID: 1724785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and qualitative aspects on the distribution of 5-HT and its coexistence with substance P and TRH in cat ventral medullary neurons.
    Arvidsson U; Cullheim S; Ulfhake B; Luppi PH; Kitahama K; Jouvet M; Hökfelt T
    J Chem Neuroanat; 1994 Jul; 7(1-2):3-12. PubMed ID: 7528511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the immunohistochemical localization of a presumptive proctolin-like peptide, thyrotropin-releasing hormone and 5-hydroxytryptamine in the rat central nervous system.
    Holets VR; Hökfelt T; Ude J; Eckert M; Penzlin H; Verhofstad AA; Visser TJ
    Brain Res; 1987 Apr; 408(1-2):141-53. PubMed ID: 3109686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional distribution of substance P- and thyrotrophin-releasing hormone-like immunoreactivity and indoleamines in the rabbit spinal cord.
    Fone KC; Bennett GW; Marsden CA
    J Neurochem; 1987 Apr; 48(4):1027-32. PubMed ID: 2434614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences of both thyroid and bovine growth hormones on substance P, thyrotropin-releasing hormone, serotonin and 5-hydroxyindoleacetic acid contents in the lumbar spinal cord of developing rats.
    Savard P; Blanchard LM; Mérand Y; Bédard P; Dussault JH; Dupont A
    Brain Res; 1984 Mar; 315(1):105-10. PubMed ID: 6202374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional distribution of immunoreactive-thyrotrophin-releasing hormone and substance P, and indoleamines in human spinal cord.
    Bennett GW; Nathan PA; Wong KK; Marsden CA
    J Neurochem; 1986 Jun; 46(6):1718-24. PubMed ID: 2422323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic immobilization stress: evidence for decreases of 5-hydroxy-tryptamine immunoreactivity and for increases of glucocorticoid receptor immunoreactivity in various brain regions of the male rat.
    Kitayama I; Cintra A; Janson AM; Fuxe K; Agnati LF; Eneroth P; Aronsson M; Härfstrand A; Steinbush HW; Visser TJ
    J Neural Transm; 1989; 77(2-3):93-130. PubMed ID: 2760606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for 5-hydroxytryptamine, substance P, and thyrotropin-releasing hormone in neurons innervating the phrenic motor nucleus.
    Holtman JR; Norman WP; Skirboll L; Dretchen KL; Cuello C; Visser TJ; Hökfelt T; Gillis RA
    J Neurosci; 1984 Apr; 4(4):1064-71. PubMed ID: 6201597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptamine nerve cell groups of the rostral ventromedial medulla.
    Kitayama I; Janson AM; Cintra A; Fuxe K; Agnati LF; Ogren SO; Härfstrand A; Eneroth P; Gustafsson JA
    J Neural Transm; 1988; 73(3):191-203. PubMed ID: 3210008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of 125I-galanin binding sites, immunoreactive galanin, and its coexistence with 5-hydroxytryptamine in the cat spinal cord: biochemical, histochemical, and experimental studies at the light and electron microscopic level.
    Arvidsson U; Ulfhake B; Cullheim S; Bergstrand A; Theodorson E; Hökfelt T
    J Comp Neurol; 1991 Jun; 308(1):115-38. PubMed ID: 1714921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between serotonin, thyrotropin-releasing hormone, and substance P in the CNS regulation of adrenocortical secretion.
    Saphier D; Welch JE; Farrar GE; Nguyen NQ; Aguado F; Thaller TR; Knight DS
    Psychoneuroendocrinology; 1994; 19(8):779-97. PubMed ID: 7527566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment.
    Iverfeldt K; Peterson LL; Brodin E; Ogren SO; Bartfai T
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):1-6. PubMed ID: 2426604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.